Sunshine Biopharma Inc. Business Combination, Assets and Liabilities Arising from Contingencies, Amount Recognized, Net
Sunshine Biopharma Inc. (SBFM) had Business Combination, Assets and Liabilities Arising from Contingencies, Amount Recognized, Net of $533.92 thousand as of 2022-10-20, per its 10-K filed 2023-04-04.
Discontinued › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation
us-gaap:BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized · last filed 2023-04-04
- 2022-10-20: Business Combination, Assets and Liabilities Arising from Contingencies, Amount Recognized, Net $533.92K.
| Period end | Business Combination, Assets and Liabilities Arising from Contingencies, Amount Recognized, Net |
|---|---|
| 2022-10-20 | $533.92K 10-K · filed 2023-04-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |